Dr. Peter D. Whooley
Overview
Peter Whooley is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Whooley has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Anal Cancer, Stomach Cancer, Chromophobe Renal Cell Carcinoma, and Pancreatic Cancer.
His clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
330 Brookline Avenue, Boston, MA 02215
Additional Areas of Focus
Dr. Whooley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Massachusetts General Physicians Organization Inc
Jill Allen is an Oncologist in Boston, Massachusetts. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Anal Cancer, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Allen is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Anuj Patel is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Patel has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Familial Pancreatic Cancer, Familial Colorectal Cancer, Pancreatic Cancer, and Anal Cancer. Dr. Patel is currently accepting new patients.
The General Hospital Corporation
Jeffrey Clark is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Clark is rated as an Elite provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Clark is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anal CancerDr. Whooley isExperienced. Learn about Anal Cancer.
- Appendix CancerDr. Whooley isExperienced. Learn about Appendix Cancer.
- Chromophobe Renal Cell CarcinomaDr. Whooley isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Colorectal CancerDr. Whooley isExperienced. Learn about Colorectal Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Whooley isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Familial Colorectal CancerDr. Whooley isExperienced. Learn about Familial Colorectal Cancer.